Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase III randomized trial comparing neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma.

Autor: Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Patil VM; Department of Medical Oncology, P D Hinduja Hospital & Medical Research Centre, Mumbai, Khar & Mahim., Menon N; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shah MJ; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Singh A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Goud S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Shah S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., More S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Nawale K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Nakti D; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Yadav A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jogdhankar S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar R; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Tiwari VK; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Niyogi D; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Purandare N; Department of Nuclear Medicine, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Janu A; Department of Radiodiagnosis, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Chakrabarty N; Department of Radiodiagnosis, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Mahajan A; Department of Imaging, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdon and Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom., Tibdewal A; Department of Radiation Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Agarwal J; Department of Radiation Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Pawar A; Department of Biostatistics, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Chowdhury OR; Department of Biostatistics, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Sharma V; Department of Medical Oncology, Yatharth Superspeciality Hospital, Noida Extension, Uttar Pradesh, India., Kapu V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Trika M; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar SV; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kolkur M; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Bhagyavant P; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Peelay Z; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Khedkar R; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Jain M; Department of Pathology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Badwe R; Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Mumbai, India., Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.